Hugh McMillan
Investigator
Professor, Pediatric Neurology, University of Ottawa
Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario
NMD4C Involvement: Pillar 2: Clinical Research
Email HughBiography
Dr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa. He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute
He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook. He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.
Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.
Recent Publications
Ward, LM, Jackowski, S, Dang, UJ, B Comm, MS, Jaremko, JL, Koujok, K et al.. Muscle function, linear growth, and bone health during 30 months of vamorolone, prednisone, and deflazacort treatment for Duchenne muscular dystrophy: a comparative study. J Bone Miner Res. 2026. PMID:42954866
Smith, IC, Grant, A, Lessard, LER, Osman, H, Oelbrandt, F, Lochmüller, H et al.. Socioeconomic costs and health-related quality of life associated with oculopharyngeal muscular dystrophy. Front Public Health. 2026.14 1918801 PMID:42935765
McMillan, HJ, Osman, H, Kernohan, K, Lacaria, M, Hume, SL, Muranyi, A et al.. Nationwide Implementation of Newborn Screening for Spinal Muscular Atrophy in Canada. Neurol Genet. 2026.12 (6)e200451 PMID:42899123
Rutter, MM, Crane, JL, Babalola, F, Benjamin, RW, Lam, C, McAdam, L et al.. Managing growth and puberty concerns in individuals with Duchenne muscular dystrophy: Updated guidance and future directions. J Neuromuscul Dis. 2026. 22143602261486896 PMID:42857968
Sbrocchi, AM, Ahmet, A, Kinnett, K, Lautatzis, ME, McMillan, HJ, Apkon, S et al.. A structured approach to address variability in the global management of adrenal insufficiency in Duchenne muscular dystrophy: the 2025 PJ Nicholoff steroid protocol. Front Neurol. 2026.17 1926817 PMID:42787106
See more on PubMed